The prediction of the therapeutic response to cholesterol lowering drugs in an 11-year-old boy with homozygous familial hypercholesterolaemia.
Bakker
H D
HD
Emma Kinderziekenhuis, Division of Paediatrics, Academic Medical Centre (AMC), Amsterdam, The Netherlands.
Bruin
T
T
Schaap
M C
MC
Lansberg
P J
PJ
Kastelein
J J
JJ
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002648:Child; D002784:Cholesterol / Q000097:blood; D006720:Homozygote; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D008077:Lipoproteins, LDL / Q000097:blood / Q000378:metabolism; D008148:Lovastatin / Q000031:analogs & derivatives / Q000627:therapeutic use; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D008297:Male; D011237:Predictive Value of Tests; D011956:Receptors, Cell Surface / Q000378:metabolism; D018110:Receptors, Lipoprotein; D019821:Simvastatin; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D011956:Receptors, Cell Surface; D018110:Receptors, Lipoprotein; D014280:Triglycerides; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin